Next generation sequencing is a high-throughput sequencing that enables sequencing and assembling of number of short DNA reads at a small period of time and with a better accuracy. Next-generation sequencing (NGS) technologies have progressive advantages in terms of cost-effectiveness, unprecedented sequencing speed, high resolution and accuracy in genomic analyses.  

The report titled “Global Next Generation Sequencing Market- Growth, Future Prospects and Competitive Analysis, 2015–2025” offers strategic insights into the overall Next Generation Sequencing market along with the market size and estimates for the duration 2017 to 2025. The research study covers in-depth analysis of market segments based on technology type, applications, and different geographical region.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global Next Generation Sequencing market, attractive investment proposition and market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Geographically, the global Next Generation Sequencing market is studied for the following regional markets:

• North America
  
  • U.S.
  • Canada
• Europe
  
  • U.K.
  • Germany
  • Rest of Europe
• Asia-Pacific
  
  • China
  • Japan
  • Rest of Asia Pacific
• Rest of the World

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2015-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global Next Generation Sequencing market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global Next Generation Sequencing market. This report concludes with company profiles section that highlights major information about the key players engaged in global Next Generation Sequencing market. In-depth competitive environment analysis and historical years (2014 and 2015) market size data are also provided in the report. 

Thus, the research study provides a holistic view of the global Next Generation Sequencing market, offering market size and estimates for the period from 2017 to 2025, keeping in mind the above-mentioned factors.

Based on the type of application, the next generation sequencing market is segmented into:

• Oncology
• Genetic Screening
• Infectious Diseases
• Drug and Biomarker Discovery
• Agriculture & Animal Research
• Idiopathic Diseases
• Others

Next-generation sequencing (NGS) technologies have progressive advantages in terms of cost-effectiveness, unprecedented sequencing speed, high resolution and accuracy in genomic analyses. Various applications of next generation sequencing are broadly categorized into oncology, genetic screening, infectious diseases, drug and biomarker discovery, agriculture & animal research, idiopathic diseases and others. Technological developments in the next generation sequencing market are expected to enable researchers to generate phase resolved HLA sequences in single read cycles and provide insight into the lesser accessible regions of HLA genes. Furthermore, the development of prenatal genome sequencing for analysis of genetic anomalies and diseases is also expected to witness enhanced demand, thus driving the genetic screening market. Growing incidences of cancer and infectious diseases, and increasing use of next generation sequencing to develop biopharmaceuticals and drugs for their cure are further expected to drive demand for next generation sequencing. The aforementioned factors are expected to serve as high impact rendering factors responsible for sustained high growth of the next generation sequencing market throughout the forecast period.

Based on the type of technology, the next generation sequencing market is segmented into:

• Whole Genome Sequencing
• Targeted Resequencing
• RNA Sequencing
• Whole Exome Sequencing
• De Novo Sequencing

Technologically, the approaches for any next generation sequencing procedure can be categorized into whole genome sequencing, targeted resequencing, Rna sequencing, whole exome sequencing and de novo sequencing. The primary difference between the approaches is the number of base pairs sequenced in a given sequencing cycle. With the advancement in technology and development of high throughput sequencing platforms such as HiSeq and MiSeq, it has become increasingly efficient to sequence larger number of base pairs in single cycle reads. Targeted resequencing has a sequencing range of genes less than 1 million base pairs in length, whereas the technological advancements in NGS sequencing technology have enabled efficient and rapid sequencing capacity to read the entire human genome which consists of 3 billion base pairs. Targeted resquencing held the largest share in the global next generation sequencing market due to its accuracy, and its rising preferences in the research and development. De novo sequencing is anticipated to grow at the fastest rate during the forecast period due to its faster, more accurate characterization of any species compared to traditional methods.

For the purpose of this study, the global next generation sequencing market is categorized as follows:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

For the purpose of this study, the global next generation sequencing market is segmented into regional markets viz., North America, Europe, Asia Pacific, Latin America, Middle East and Africa. In the base year 2015, North America was observed as the largest revenue generating market for next generation sequencing market, where the U.S. held the largest market share. The major factors driving the market are technological advancements in the field of life sciences, availability of commercial solutions for next generation sequencing data analysis, and presence of key players in the region. Moreover, extended support from the government institution for genomic research for drug discovery and genetic screening is also driving the market for next generation sequencing in North America and Europe. Asia-Pacific is expected to grow at the fastest rate with throughout the forecast period owing to growing medical awareness in the regional population, increasing investment for development of healthcare and rising oncology and infectious disease research in the region.